NORTHERN TRUST CORP - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$67,000
+3.1%
49,933
+12.9%
0.00%
Q2 2020$65,000
+75.7%
44,225
+12.1%
0.00%
Q1 2020$37,000
-41.3%
39,4630.0%0.00%
Q4 2019$63,000
-54.3%
39,463
-1.5%
0.00%
Q3 2019$138,000
-80.0%
40,081
-78.6%
0.00%
Q2 2019$690,000
-64.3%
186,901
+1.5%
0.00%
Q1 2019$1,931,000
+8.2%
184,064
+7.2%
0.00%
-100.0%
Q4 2018$1,785,000
-13.0%
171,750
+0.9%
0.00%0.0%
Q3 2018$2,051,000
+355.8%
170,243
+349.0%
0.00%
Q2 2018$450,000
+56.2%
37,915
+103.1%
0.00%
Q1 2018$288,000
+37.8%
18,669
+20.3%
0.00%
Q4 2017$209,000
+2.0%
15,518
+27.4%
0.00%
Q3 2017$205,00012,1840.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 951,701$9,983,0001.12%
Morse Asset Management, Inc 149,175$1,565,0000.47%
SECTORAL ASSET MANAGEMENT INC 276,656$2,902,0000.35%
PARSONS CAPITAL MANAGEMENT INC/RI 276,963$2,905,0000.32%
CAXTON CORP 23,717$249,0000.23%
TIEDEMANN ADVISORS, LLC 412,049$4,323,0000.20%
Private Capital Advisors, Inc. 52,335$549,0000.17%
Pegasus Asset Management, Inc. 18,750$197,0000.16%
Hikari Power Ltd 53,536$562,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 51,015$535,0000.05%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders